Twist Bioscience Dirección
Dirección controles de criterios 3/4
El CEO de Twist Bioscience es Emily Leproust , nombrado en Apr 2013, tiene una permanencia de 11.58 años. compensación anual total es $8.00M, compuesta por 8.6% salario y 91.4% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.47% de las acciones de la empresa, por valor de $11.84M. La antigüedad media del equipo directivo y de la junta directiva es de 2.6 años y 8 años, respectivamente.
Información clave
Emily Leproust
Chief Executive Officer (CEO)
US$8.0m
Compensación total
| Porcentaje del salario del CEO | 8.6% |
| Permanencia del CEO | 11.6yrs |
| Participación del CEO | 0.5% |
| Permanencia media de la dirección | 2.6yrs |
| Promedio de permanencia en la Junta Directiva | 8yrs |
Actualizaciones recientes de la dirección
Recent updates
Twist Bioscience: A Post-Earnings Assessment
Nov 18Twist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy'
Nov 08Twist Bioscience (NASDAQ:TWST) Is In A Strong Position To Grow Its Business
Sep 25
Investors Aren't Buying Twist Bioscience Corporation's (NASDAQ:TWST) Revenues
Aug 20Twist Bioscience: Lowered Biopharma Expectations Amid Financial Strain (Rating Downgrade)
Aug 04Twist Bioscience: Growing Customer Base And Technology Platform Make Me Like This Stock
Jul 26We Think Twist Bioscience (NASDAQ:TWST) Can Easily Afford To Drive Business Growth
Jun 10Twist Bioscience Corporation (NASDAQ:TWST) Shares Fly 29% But Investors Aren't Buying For Growth
May 04Twist Bioscience: NGS Is Taking Off
May 03Twist Bioscience Corporation (NASDAQ:TWST) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Feb 27Twist Bioscience: Strong Performance In A Soft Market
Feb 07Here's Why Shareholders May Want To Be Cautious With Increasing Twist Bioscience Corporation's (NASDAQ:TWST) CEO Pay Packet
Jan 31We're Not Very Worried About Twist Bioscience's (NASDAQ:TWST) Cash Burn Rate
Jan 22Twist Bioscience Corporation's (NASDAQ:TWST) Price Is Right But Growth Is Lacking After Shares Rocket 44%
Dec 18Twist Bioscience (NASDAQ:TWST) Is In A Good Position To Deliver On Growth Plans
Oct 05We Think Twist Bioscience (NASDAQ:TWST) Can Afford To Drive Business Growth
Jul 07Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$209m |
| Jun 30 2024 | n/a | n/a | -US$220m |
| Mar 31 2024 | n/a | n/a | -US$192m |
| Dec 31 2023 | n/a | n/a | -US$206m |
| Sep 30 2023 | US$8m | US$685k | -US$205m |
| Jun 30 2023 | n/a | n/a | -US$209m |
| Mar 31 2023 | n/a | n/a | -US$213m |
| Dec 31 2022 | n/a | n/a | -US$214m |
| Sep 30 2022 | US$6m | US$665k | -US$218m |
| Jun 30 2022 | n/a | n/a | -US$208m |
| Mar 31 2022 | n/a | n/a | -US$188m |
| Dec 31 2021 | n/a | n/a | -US$165m |
| Sep 30 2021 | US$1m | US$590k | -US$152m |
| Jun 30 2021 | n/a | n/a | -US$135m |
| Mar 31 2021 | n/a | n/a | -US$123m |
| Dec 31 2020 | n/a | n/a | -US$117m |
| Sep 30 2020 | US$7m | US$519k | -US$140m |
| Jun 30 2020 | n/a | n/a | -US$147m |
| Mar 31 2020 | n/a | n/a | -US$147m |
| Dec 31 2019 | n/a | n/a | -US$141m |
| Sep 30 2019 | US$8m | US$477k | -US$108m |
| Jun 30 2019 | n/a | n/a | -US$96m |
| Mar 31 2019 | n/a | n/a | -US$86m |
| Dec 31 2018 | n/a | n/a | -US$77m |
| Sep 30 2018 | US$525k | US$362k | -US$71m |
Compensación vs. Mercado: La compensación total ($USD8.00M) de Emily está en línea con el promedio de empresas de tamaño similar en el mercado US ($USD6.54M).
Compensación vs. Ingresos: La compensación de Emily ha aumentado mientras la empresa no es rentable.
CEO
Emily Leproust (51 yo)
11.6yrs
Permanencia
US$7,998,637
Compensación
Dr. Emily Marine Leproust, Ph.D. serves as Independent Director at CM Life Sciences, Inc. since September 2, 2020. She serves as an Independent Director at GeneDx Holdings Corp. (formerly known as Sema4 Ho...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 11.6yrs | US$8.00m | 0.47% $ 11.8m | |
| President & COO | 2.1yrs | US$5.23m | 0.13% $ 3.2m | |
| Senior Vice President of Human Resources | 8.7yrs | US$2.49m | 0.060% $ 1.5m | |
| Senior VP of Advanced Development | 4.8yrs | US$2.82m | 0.44% $ 10.9m | |
| Chief Financial Officer | less than a year | sin datos | 0.012% $ 292.5k | |
| VP & Chief Accounting Officer | 1.5yrs | sin datos | 0.016% $ 392.5k | |
| Chief Technology Officer | 3.8yrs | sin datos | sin datos | |
| Chief Information Officer | less than a year | sin datos | sin datos | |
| Senior VP | 3.2yrs | US$1.96m | 0.067% $ 1.7m | |
| Senior Vice President of Sales & Support | no data | sin datos | sin datos | |
| Chief ESG Officer & Senior VP of Corporate Affairs | 3.8yrs | sin datos | sin datos | |
| Senior Vice President of Operations | 1.1yrs | sin datos | sin datos |
2.6yrs
Permanencia media
52yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de TWST se considera experimentado (2.6 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| Co-Founder | 11.6yrs | US$8.00m | 0.47% $ 11.8m | |
| Senior VP of Advanced Development | 11.6yrs | US$2.82m | 0.44% $ 10.9m | |
| Independent Director | 11.1yrs | US$272.49k | 0.16% $ 4.0m | |
| Lead Independent Director | 10.3yrs | US$303.98k | 0.11% $ 2.7m | |
| Independent Director | 5.5yrs | US$284.99k | 0.030% $ 754.5k | |
| Independent Director | 8yrs | US$271.34k | 0.023% $ 574.3k | |
| Independent Director | 6.1yrs | US$284.99k | 0.020% $ 490.5k | |
| Independent Director | 3.3yrs | US$276.61k | 0.018% $ 459.7k | |
| Independent Director | 6.3yrs | US$269.99k | 0.043% $ 1.1m |
8.0yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: La junta directiva de TWST se considera experimentada (8 años de antigüedad promedio).